An analysis of the 2028 Medicare Drug Price Negotiations draft guidance and the implications for manufacturers.

Asembia once again delivered on its reputation as the premier event for specialty pharmacy and pharmaceutical distribution, with expanded themes around operational readiness, Gross to Net forecasting, and the need for integrated analytics and scenario planning across the commercialization lifecycle.

New Drug Reporting related to State Price Transparency laws can be a heavy lift. With our guidance and the STARS system, it doesn't have to be.

Optimizing GTN forecasting is a necessity. Get a recap of our webinar with Twelve Consulting covering this and contact us for more info.

New Jersey has released their Drug Affordability Unit website. Manufacturers must submit required information retroactively from 8/1/2024.

State price transparency regulations are ever changing. Read on to learn about the capabilities necessary to manage them.

Emerging pharmaceutical companies often underestimate the extensive preparation required before a drug launch. Effective pre-launch...

Learn how connecting Demand Forecasting and Supply Planning improves both functions leading to optimized GTN forecasts.

Pharmaceutical manufacturers across the board grapple with the complexities of Gross to Net (GTN) forecasting. While the allure of a...

New York's new law requires 60 days advance notice, while parts of Oregon's law are declared unconstitutional.

Pharosity will be attending Asembia Specialty Summit in Las Vegas this year.

Pharosity will be attending the MDRP Conference in New Brunswick, NJ

We are excited to be hosting a webinar with our friends from Twelve Consulting Group titled Connected Planning Across the Pharma Gross to...

A sneak peak at some of the recent efforts we have made to stay current with the ever-changing (and often confusing) regulations.

If you're attending the conference, check out our session with Twelve Consulting as we discuss GTN through the lens of connected planning.

The Trump Administration resurrected the rebate rule in an EO published 7/24/2020. Read the white paper we published on the topic last year.

Join Rob Ririe from Pharosity Consulting as he and representatives from Greenwich Biosciences discuss the challenges and opportunities of...

Pharosity Consulting's Mike McCarthy will be moderating a panel discussion titled "Actively Managing Gross-to-Net to Drive Growth and Value"

Pharosity Consulting will be presenting at this year's CBI GTN conference, November 15th and 16th, at the Hilton Philadelphia Penn's...

Join Pharosity Consulting at the MDRP conference in Chicago, October 1st - 3rd at the Renaissance Chicago Downtown. There, we will be...